StockWatch
·

SOMANY CERAMICS LTD. Q2 FY27 Results

SOMANYCERAQ2 FY27 Results
Filing
Result:Good· Market: Crashed#Margin expansion#Broad based

Outlook: Cautiously Optimistic · Guidance: Raised

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue860.6514.8%25.6%
Total Income862.8214.6%25.3%
Expenditure800.3413.8%19.4%
PBT60.1120.8%223.5%
Net Profit41.5621.4%237.6%
OPM11.31%0.19pp3.50pp
NPM4.82%0.27pp3.03pp
EPS10.1216.9%177.3%
View full financials

Revenue growth of 25.6% with OPM expanding from 7.81% to 11.31% drove PAT up 237.6% off a depressed base, so core business improvement is real but the magnitude is inflated by a weak year-ago comparator, capping it short of very_good.

SOMANY CERAMICS · Q2 FY27 · THE VERDICT

Revenue soars, volumes lag; margins eyed — but price/mix is doing the heavy lifting

Reported profit jumped 238%, but volume growth slowed to just 5.5% and the gains are price-driven, not volume-driven. Management reset guidance lower and pivoted to a multi-year margin expansion story anchored on capex firing next year.

11 Nov 2026 · 6 min read
Reported PAT

₹41.6 Cr

+237.6% YoY

JV swing impact

₹15 Cr

₹12 Cr loss → ₹3 Cr profit; H1 ₹23 Cr loss → ₹6 Cr profit

Organic growth

~20%

PAT excl. JV swing; more modest

Volume growth

5.5%

Q2; guidance reset to 7–8% Q3

On the headline, this quarter looks like a blowout. Revenue ₹860.6 Cr is up 25.6% year-over-year, and net profit ₹41.6 Cr has soared 238%. But dig in, and the story narrows. Of that PAT growth, ₹15 crore swung from a ₹12 crore JV loss in Q2 prior to a ₹3 crore profit now — a one-off swing that masks a weaker organic picture. Strip it out, and earnings growth sits closer to 20%, not 238%. More troubling: the revenue growth is almost entirely price-and-mix, not volume. Volume rose just 5.5%, while price and product mix accounted for roughly 19% of the top-line pop. That's the tension the quarter doesn't resolve.

Q2 FY27 contribution to revenue growth
09.5619.1128.675.5Volume19Price/mix25.6Total
Volume lagged; price and product mix drove 74% of the growth. This raises a critical question: how sticky is that pricing once inflation moderates or global demand softens further?

Where volume stumbled

Management attributed the soft 5.5% volume growth to one-off maintenance disruptions: 20 days of downtime in July, another 15 days in August. On the call, they pointed to Q3 expectations of 7–8% volume growth and framed Q2 as an anomaly. But that reset is telling. In the prior earnings call (Q1 FY27), the guidance tilted toward mid-single-digit volume growth with upside from capex. 5.5% is at the lower end of that band, not an upside case. It comes against a backdrop of a 31.2% industry export decline — Morbi (the ceramic export hub) is 35–45% shut due to geopolitical pressures and freight cost shocks. While Somany's domestic tiles sales grew 25% and exports also grew 25%, the company had to overcome a severely constrained market to show that growth. The question isn't whether Somany can execute; it's whether the export market recovery actually arrives in Q3, as management expects post-Diwali.

What holds up; what doesn't

Management's key claims vs. the delivered result

Revenue up 25%, volume up 5.5%.

What holds up

Delivered ₹860.6 Cr (+25.6% YoY), volume +5.5% confirmed. Price/mix outpaced volume; internal consistency checks out.

Verdict

Supported

EBITDA margin 11.7% driven by better utilization and improved JVs.

What holds up

Delivered OPM 11.3%. EBITDA claim of 11.7% is plausible (EBITDA > OPM). JV swing from ₹12 Cr loss to ₹3 Cr profit confirmed in H1 data (₹23 Cr loss → ₹6 Cr profit).

Verdict

Supported; JV swing is real but cyclical

GVT (glazed vitrified tiles) mix now 45%, targeting 65–70% by 2028–29 via South plant.

What holds up

45% current mix stated on call. South Siravit plant expansion is 16M sq m, all-GVT. Expansion timeline Sept 2027. Not contradicted by Q2 numbers.

Verdict

Supported

Gas price ₹70/SCM, full pass-through achieved; 16–17% price increases April to now.

What holds up

Q2 revenue +25.6% with volume +5.5% = ~19% price/mix uplift, consistent with gas pass-through + other inflation.

Verdict

Supported by the data

Morbi exports down 31% industry-wide, but Somany tiles +25%.

What holds up

Industry export decline -31.2% confirmed. Somany tiles (₹723 Cr segment) up 25%. Market share gain in organized sector.

Verdict

Supported

Sanitaryware +20%, building solutions +28% in Q2.

What holds up

Q2 segment growth as stated. Both are high-margin, low-volume products. Expansion capacity online Sept 2027.

Verdict

Supported but still small % of revenue (16–17% total; target 22–25% in 2–3 yrs)

What changed on this call

  • EBITDA margin guidance raised: prior call guided 1–1.5% improvement in FY27 over FY26; this call revised to 2–2.5% improvement, now targeting 11.5–12%.

  • Volume growth reset lower: prior call tilted toward double-digit aspiration; Q2 delivered 5.5%, guidance now 7–8% Q3, single-digit FY27 full year.

  • JV profitability turned: Q2 prior was ₹12 Cr loss; this Q2 ₹3 Cr profit. H1 swing from ₹23 Cr loss to ₹6 Cr profit.

  • South capex structure refined: original guidance ₹275 Cr FY27–28 split (65–70% equity). Revised: ₹250 Cr South Siravit, ₹60 Cr Somany side + routine modernization, 50–50 debt-equity split.

  • Sanitaryware & building solutions emerging: +20% and +28% growth Q2; now 16–17% of revenue, targeted 22–25% by 2028–29.

The bull-bear ledger

  • Revenue growth real and pricing power evident (16–17% pass-through achieved)

  • EBITDA margin guidance raised; 11.7% delivered, on track to 12%

  • Market share gain: Somany tiles +25% despite industry export decline of 31%

  • South plant capex on track (Sept 2027 firing); GVT ramp mechanism is concrete

  • JV profitability turnaround; H1 swing from ₹23 Cr loss to ₹6 Cr profit

  • Sanitaryware +20%, building solutions +28%; high-margin, capacity expanding

  • Volume growth disappointing (5.5% vs. double-digit prior aspiration)

  • Revenue growth price-driven (19% mix, 5.5% volume) — sustainability question

  • JV swing inflates PAT +238%; organic growth closer to 20%

  • Net profit margin thin (4.8% NPM); interest and tax burden high

  • Export headwind real (industry -31%); Morbi 35–45% shut; recovery timeline uncertain

  • South plant delay would push GVT ramp and margin expansion to FY29

  • Gas price volatility (₹70/SCM) remains; full pass-through may not hold if demand weakens

Ranked risks: what should concern a holder

Risk factors, ordered by severity and holder impact

Geopolitical export headwind; Morbi export hub 35–45% shut (Ukraine war fallout on freight)

Medium

Industry exports down 31.2%. Somany offset with domestic growth and pricing, but global recovery is uncertain. If geopolitical risk persists, export volume may remain pressured into FY28.

Volume growth deceleration; only 5.5% Q2, reset to 7–8% Q3 and single-digit FY27

Medium

Prior call hinted at double-digit growth potential. 5.5% Q2 is below expectation. If export market doesn't recover and domestic demand softens, volume may stay in 5–6% range, delaying capex upside.

South plant capex execution; ₹250 Cr target, Sept 2027 production deadline

Medium

Delay would push GVT capacity ramp (16M sq m) to FY29, deferring margin expansion from 2–3 years to 3–4 years. The margin guidance 11.5–12% FY27 and 13%+ in 2–3 years hinges on this capex.

JV profitability swing is cyclical; H1 ₹23 Cr loss → ₹6 Cr profit is 7–15% of Somany profit

Low

If utilization or margins decline in JVs, profit could swing back. Not core Somany, but magnitude is material enough to dent earnings if it reverses.

Gas price volatility (current ₹70/SCM, FY26 was ~₹45); pricing power may cap if demand softens

Low

Full pass-through achieved Q2, but if global inflation moderates or export demand weakens, pricing power may face headwinds.

How the market is positioned

The stock trades at ₹544.15, off 44% from its all-time high and up 64% from its 52-week low. It sits below the 20-day and 50-day moving averages (₹561 and ₹575) but above the 200-day average (₹489), suggesting a pullback within a longer-term uptrend. RSI sits at 43.8 (neutral). Volume is increasing into the dip — a sign of accumulation.

Institutional ownership is cautious. FII holdings are minimal (1.38%), while DII trimmed their position quarter-over-quarter, dropping from 21.6% in Q4 FY26 to 19.4% in Q1 FY27 — a 221 basis point retreat. Promoters hold steady at 55.2%. The DII exit suggests domestic institutions are stepping back, likely pricing in volume deceleration and waiting for proof of recovery in Q3. That's a warning sign.

The valuation drawdown is significant, but it may be justified. The stock has fallen 44% from peak precisely because the market was pricing in higher volume growth and a faster margin ramp. Q2's 5.5% volume and the reset to single-digit growth for full-year FY27 are disappointments against that backdrop. However, the drawdown also creates an opportunity — if South plant capex fires on time (Sept 2027) and volume accelerates to 7–8% or higher in Q3, the risk-reward tilts favorably.

The debate

What to watch next

The three-number test
  • 1 · Q3 volume growth (target: 7–8%)

    Management guided 7–8% volume for Q3, citing end of maintenance disruptions and seasonal demand strength. This is the make-or-break number. If volume misses and lands at 4–5% again, the capex story loses credibility. If it hits 7–8%+, the export recovery narrative holds.

  • 2 · South plant capex progress (Sept 2027 production deadline)

    Management stated the facility will fire in production 'exactly same time next year' (Sept 2027). Watch quarterly updates for construction milestones, equipment orders, and hiring ramps. Any delay signals that the margin expansion (11.5–12% to 13%+ by 2029) slips.

  • 3 · GVT mix progression (current 45%, target 65–70% by 2028–29)

    GVT (higher-margin product) is key to the margin story. Track quarterly mix data. If GVT can hold or grow faster, it signals pricing power and product acceptance. If mix stalls or slides, margin expansion will be slower than guided.

The single number to track

Organic EBITDA margin, excl. JV swings. The headline is EBITDA 11.7% (guided 11.5–12% for FY27). But strip out the JV swing, and core Somany margin is closer to 11.3% (operating margin). If that can climb to 11.5–12% in Q3–Q4 without JV help, the margin guidance is real. If JV profit is needed to hit target, the story is fragile. That single metric tells you whether the company is executing on operational leverage or relying on one-off items.

Somany delivered a headline-positive quarter: revenue ₹860.6 Cr (+25.6% YoY), OPM 11.3% on track to 12%, and a plausible three-year margin ramp story anchored on South plant and GVT mix shift. But the quarter also revealed a key constraint: volume growth at 5.5% is softer than management's prior double-digit aspiration, and price-mix inflation is doing 74% of the heavy lifting. That's not sustainable.

The reset to single-digit volume guidance (5.5% Q2, 7–8% Q3, single-digit FY27) and the acknowledgment of export headwinds (industry -31%, Morbi 35–45% shut) suggest management is being candid about near-term demand pressures. That's credibility, but it also means the upside is contingent, not assured.

Valuation-wise, the 44% drawdown from ATH and the DII trimming suggest the market has already priced in disappointment. If Q3 volume hits target (7–8%+) and South plant capex stays on track (Sept 2027 production), this stock offers asymmetric upside from current levels. But if either slips, the holding pattern extends, and patience will be tested.

Verdict: Hold. Steady business, real capex catalyst, but volume proof required. Watch Q3.

Informational and educational content only. Not investment advice.